Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene
NCT03905317
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Lung Adenocarcinoma
Interventions
DRUG:
Bevacizumab Injection
RADIATION:
chest radiation
DRUG:
concurrent chemotherapy
Sponsor
Sun Yat-sen University